{"a":[{"_":"Ori locks down $120M pact to deploy automated production platform for unnamed, commercial cell therapy","$":{"href":"/pharma/ori-locks-down-120m-pact-deploy-automated-production-platform-unnamed-commercial-cell","hreflang":"en"}}]}

Summary

Ori has secured a $120 million partnership to deploy its automated cell therapy production platform for an undisclosed commercial cell therapy program. The deal represents a significant commercial validation of Ori's manufacturing technology in the cell therapy space.